©The Author(s) 2025.
World J Virol. Dec 25, 2025; 14(4): 112590
Published online Dec 25, 2025. doi: 10.5501/wjv.v14.i4.112590
Published online Dec 25, 2025. doi: 10.5501/wjv.v14.i4.112590
Table 3 Global variation in hepatitis A vaccine provision and access
| Vaccine policy | Cost coverage | Equity/operational notes | Ref. |
| Routine childhood vaccination; targeted adult vaccination (VFC program) | Free under VFC; OOP for adults without insurance | Outbreaks in PEH and drug-using adults; gaps in adult uptake | Nelson et al[41], United States |
| Targeted (indigenous, travelers, PEH) | Provincial programs; partial coverage | Uneven uptake across provinces | Palaisy[42], Canada |
| Universal childhood vaccination (≥ 12 months) | Government-funded | High coverage; regional disparities in remote areas | Brito and Souto[43], Brazil |
| Integrated in national schedule (since 2023) | Free public sector | Rapid rollout post-urban outbreaks | Guzman-Holst et al[44], Mexico |
| Universal single-dose schedule | Government-funded | Successful herd immunity; sustained low incidence | Flichman et al[45], Argentina |
| Targeted (travelers, men who have sex with men, PEH) | National Health Service covers high-risk groups | Limited adult awareness | Johnson et al[46], United Kingdom |
| Recommended (travelers, men who have sex with men, laboratory staff) | Reimbursed by insurance | Stable low incidence; high cost limits universal rollout | Szucs[47], Germany |
| Universal since 2003 in several regions | Government-funded | Decline in hepatitis A virus cases; regional autonomy causes inconsistency | Bechini et al[48], Italy |
| Targeted vaccination | Regional funding | Good outbreak response; inequity across regions | Urbiztondo et al[49], Spain |
| Included in routine childhood schedule in 2008 | Government-funded | High coverage; rare outbreaks | Ryani[50], Saudi Arabia |
| Universal childhood (since 2011) | Fully subsidized | Excellent coverage nationwide | Yigit and Kalayci[51], Turkey |
| Targeted vaccination (private market) | Mostly OOP | High-cost limits uptake; growing private sector use | Shah et al[52], India |
| Targeted; not yet universal | OOP except high-risk groups | Declining seroprevalence; debate on adding to National Immunisation Programme | Poovorawan et al[53], Thailand |
| Universal childhood vaccination since 2008 | Government-funded | Dramatic incidence decline; urban-rural gap remains | Yan et al[54], China |
| Targeted (travelers, men who have sex with men) | OOP | Low uptake; periodic import-linked outbreaks | Kanda et al[12], Japan |
| Targeted (travelers, laboratory staff) | OOP | Low uptake due to cost; increasing adult outbreaks | Patterson et al[55], South Africa |
| Not routine; private market only | OOP | High endemicity; vaccine not prioritized | Ahmed and Nashwan[56], Pakistan |
- Citation: Majeed AA, Sarfraz M, Butt AS. Evolving trends in hepatitis A epidemiology: Shifting patterns, emerging risks, and future strategies. World J Virol 2025; 14(4): 112590
- URL: https://www.wjgnet.com/2220-3249/full/v14/i4/112590.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i4.112590